Back To Search Results

Multimodal Postoperative Pain Control After Orthopaedic Surgery

Editor: Richard Harrell Updated: 1/29/2023 9:26:17 AM

Introduction

Multimodal Analgesia (MMA), also called “balanced analgesia,” uses multiple analgesic medications, physical modalities, and cognitive strategies to affect peripheral and central nerve loci for pain treatment.[1] In light of the adverse side effects of opioid medication, the MMA model of pain management allows physicians an array of medicine and other modalities to help decrease the morbidity associated with opioid analgesics often used as monotherapy. The number of drug overdoses continues to rise every year, with opioids accounting for nearly two-thirds of the cases and being the leading cause of accidental death in the United States.[2][3] Orthopedic surgeons are attributed to writing 7.7% of all opioid prescriptions while only accounting for 2.5% of all prescribing physicians.[4] 

Orthopedic surgeons are challenged with the task of pain management while mitigating the risk associated with opioids. MMA allows orthopedic surgeons and other medical professionals a more modern and evidence-based approach to treating acute pain in their patients. The use of NSAIDs, acetaminophen, gabapentinoids, immediate-release opioids, cognitive therapy, peri-articular injections, and physical modalities, such as cryotherapy, be reviewed in this topic to assist the modern orthopedic surgeon in controlling pain in their patients in the postoperative period. In addition, this topic reviews the various drug classes, adverse effects, and contraindications. It provides insight into special consideration for certain patients who are opioid-tolerant or suffer from comorbid conditions.

Function

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Function

NSAIDs

Non-steroidal anti-inflammatory drugs (NSAIDs) are common over-the-counter medications used daily for pain and inflammation. The mechanism of NSAIDs has been traditionally described by their peripheral efficacy in decreasing the pro-inflammatory mediators, prostaglandins. More recently, NSAIDs have been attributed to having a central role that augments its known peripheral action, by which it promotes the production of endogenous opioid peptides.[5] Due to fracture healing and fusion concerns, there are conflicting arguments in the orthopedic literature on the use of NSAIDs for pain control. Basic science studies have shown increased time to fusion in animal models using NSAIDs, though fracture healing has demonstrated mixed results. Hsu et al. recommend using NSAIDs in the MMA model due to a lack of high-quality evidence supporting decreased fracture healing in the clinical setting.[6] NSAIDs are proven to be effective for musculoskeletal pain, with head-to-head clinical studies noting equivalent pain control with NSAIDs compared with opioids with a reduced risk profile.[7][8] NSAIDs are used to target the associated inflammation. Recent studies have looked at the efficacy of pre-operative administration of NSAIDs and their results on postoperative pain scores. Pre-operative loading of meloxicam has decreased VAS pain scores in patients undergoing total knee arthroplasty for primary arthritis compared to post-operative administration alone.[9] A resulting decrease in the amount of patient-controlled analgesia was also seen. Contraindications with NSAIDs include peptic ulcer disease, chronic or end-stage renal disease, bronchial asthma, and breastfeeding women.[10]

Acetaminophen/Paracetamol

Acetaminophen is a commonly used over-the-counter analgesic and antipyretic. It is the most common alternative for patients who cannot use NSAIDs due to contraindications stated previously. Its mechanism of action is complex, as it acts on both the peripheral and central COX pathways, affecting the serotonergic, cannabinoid, and nitric oxide pathways [10]. Thus, it is used to target the pain cascade. Contraindications to the use of acetaminophen include liver disease or active alcohol intake, which can cause acute liver injury.

Gabapentinoids

Gabapentin, originally used as an anticonvulsant drug, is a commonly used modulator of neuropathic pain. It inhibits the trafficking of protein subunits to decrease the voltage-gated calcium channels on the plasma membrane of dorsal root ganglion neurons.[11] It has often been used in the treatment of diabetic neuropathic pain but has also been shown to be effective in treating acute pain. A meta-analysis of post-operative spine surgery showed decreased pain scores at 12 and 24 hours. In this same study, it was also shown that the addition of gabapentin to the normal post-operative pain regimen showed a significant decrease in total morphine consumption, as well as decreased vomiting, pruritus, and urinary retention, which are associated with morphine use.[12] 

Gabapentin is a scheduled drug that has been misused in opioid-addicted patients. It can act to potentiate methadone high and negate symptoms of opioid withdrawal.[13] The use of gabapentin is associated with confusion, fatigue, and somnolence, which can be mitigated somewhat by using the lowest dose possible. A strategy used by some surgeons is to use gabapentin preoperatively at bedtime a couple of days before surgery. It can be increased to 2 or 3 times daily post-operatively if needed. If patients are unable to use gabapentin, then pregabalin can be substituted. Gabapentin is contraindicated in patients with myasthenia gravis and myoclonus disorders.[14][15]

Transcutaneous Electrical Stimulation (TENS)

TENS is a method of pain control in which a small voltage electrical current is delivered to the skin over the desired site of analgesia. This modality can be used in the postoperative period to stimulate large-diameter peripheral nerves, which are believed to decrease pain by activating opioid receptors through an endogenous pathway.[1] There are mixed results on the use of TENS as an adjunct to normal post-op pain control, some attributing the variation in results to the amplitude and frequency used during treatment. A meta-analysis including twenty-one randomized controlled trials found that TENS around the surgical site decreased post-op analgesic consumption by 26.5 % and decreased opioid use post-operatively by 35.5 %.[16] Contraindications to the use of TENS include severe lymphedema, compromised skin at the desired location of application, or the presence of a pacemaker or defibrillator.

Cryotherapy

Cryotherapy is a part of the traditional physical aspect of decreasing pain in an extremity, whether post-operative or treating a closed injury such as an ankle sprain. It is the use of an external cold source in an attempt to decrease the temperature of the tissue in that area. Ice packs, cold water therapy, gaseous cryotherapy, and continuous flow cryotherapy are all used in cryotherapy. The effects on tissue include decreased edema, inflammatory mediators, and blood flow via vasoconstriction or local vasculature.[17][18][19] Various studies have looked at the effect of cryotherapy after orthopedic surgeries. Studies show a decrease in pain scores as compared to controls, as well as a decrease in opioid use postoperatively when cryotherapy is used in conjunction with traditional methods of pain control.[20][21][22][23][24][25] Complications with cryotherapy include nerve palsies, mostly involving superficial peripheral nerves. These injuries range from brief paresthesia to complete nerve injury without return of function. It is important to have appropriate insulation between the cold source and the targeted area. This is especially important in areas with less subcutaneous fat or patients with less fat content.[6]

Nerve Blocks

Nerve blocks include local and regional anesthesia to the targeted area. Nerve blocks are commonly used methods of analgesia in elective orthopedic surgery cases, including arthroscopy and arthroplasty. These can be utilized preoperatively, intraoperatively, or post-operatively. Hsu et al. recommend using a continuous catheter over a single shot when administering a nerve block. They report better pain control with a decreased chance of rebound pain often associated with lower extremity blocks. Various nerve block methods may differ based on surgeon preference, depending on the patient and surgical site. Problems include rebound pain and an increased risk of falls.[6]

Opioids

As discussed previously, opioids are a common medication used for severe acute pain. Orthopedic surgeons commonly use them in the post-operative period for pain control. There are significant risks associated with their use, including misuse, addiction, and overdose. Opioids bind the mu-opioid receptor and inhibit neurotransmitter release in the central nervous system. In their clinical practice guidelines, Hsu et al. recommend that opioids be used in the smallest dose and for the shortest amount of time possible. Short-acting opioids are preferred and recommended, as compared to long-acting opioids, which provide less opioid absorption per unit of time.[6] The oral administration of opioids is preferred to IV administration in postoperative patients who can tolerate the oral route. Pain scores are equivalent, with fewer morphine equivalents ingested in the oral administration group.[26] 

Multiple sources strongly recommend that opioids not be prescribed in conjunction with benzodiazepines due to the risk of increased sedation, overdose, and abuse. Park et al. noted a 3.9-time increase in overdose due to respiratory depression when using opioids in conjunction with benzodiazepines.[27] Opioids have been noted to be very effective and act synergistically when used with NSAIDs, compared to opioids as monotherapy.[28] Wojahan et al looked at the number of opioids consumed after knee arthroscopy and observed that 81 % of patients take fewer than twenty pills postoperatively.[29] This leads to the notion that when utilizing opioids in the postoperative patient, orthopedic surgeons are writing prescriptions too high in quantity. This results in a medication surplus that is then available for misuse. This misuse may also involve diversion to use by persons not under the physician’s care. Adverse effects of opioids include nausea, vomiting, dizziness, constipation, somnolence, and headache.

Cognitive Strategies

Cognitive strategies are great tools to implement for all patients before and after surgery. Providing patients with an appropriate estimate or overestimate of the pain level to expect postoperatively is a good strategy to help prepare patients for their surgery. Patients with co-morbid psychological issues, including anxiety, low appreciation of self-worth, and major depression, have been noted to experience more pain per nociception.[30] There is significant variation in the pain perceived among patients due to varying psychosocial issues. Patients who suffer from comorbid anxiety, major depression, opioid tolerance, and low self-worth may benefit from psychiatry consultation while admitted to the hospital. The honest, direct dialogue between the surgeon and the patient is of utmost importance regarding pain relief expectations. Enlisting support for acute pain and addiction medicine services is recommended in the clinical guidelines by Hsu et al.[6]

Issues of Concern

Opioid Safety

Opioids can be associated with significant morbidity if not handled appropriately. On the other hand, they can be a great tool to control postoperative pain when used correctly in the appropriate patient. In the in-patient and out-patient setting, it is important to reassess patient pain and change the pain regimen accordingly constantly. It is particularly important in the in-patient setting that a sedation status be performed before and after administration of each opioid medication or other medications with sedating effects, for that matter. This is recommended in the clinical practice guidelines by Hsu et al.[6] 

Pasero designed an opioid sedation scale to help monitor patients and guide medication regimen changes in the in-patient setting.[31] Since sedation is an impending sign of respiratory distress, direct monitoring of the patient before and after receiving medication is vital. Hsu et al. also recommend co-prescribing naloxone for patients who are at increased risk for respiratory depression. No studies demonstrate that this directly decreases prescription overdoses. Still, it has been seen to decrease overdoses on a community scale when naloxone has been made available to illicit drug users. Patients who would benefit from this include previous drug abusers and patients with anxiety who may be prescribed benzodiazepines by other providers. It is also recommended that all physicians register and monitor the Prescription Drug Monitoring Drug Program (PDMP) before prescribing pain medication.

Clinical Significance

Multimodal analgesia is the future for the alleviation of pain in many fields of medicine. The field of orthopedic surgery has been at the forefront of this new tool's clinical use and innovation for postoperative pain relief. This model shows benefits in many ways in the clinical setting. Orthopedic surgery can often be associated with significant pain in the early postoperative period. Balancing the need for pain control while mitigating the risk of adverse effects such as opioid dependence and adverse effects of medication with comorbid conditions can be difficult. MMA provides a broad array of medications and strategies that can be combined to work synergistically with one another to help orthopedic surgeons treat their patients as productively and safely as possible. Recent studies corroborate the idea that this model helps decrease post-operative pain beyond the standard monotherapy opioid regimen. This leads to less opioid use and, therefore, less risk to the patient.[32] Individual surgeons often create their regimens for how they approach MMA. Hsu et al. have broken their pain regimens into classes based on the severity of the injury and the associated surgery. The classes include major musculoskeletal surgery, minor musculoskeletal surgery, and non-operative or closed treatment. These recommended regimens include opioid management as well as alternative or adjuvant non-opioid medications (NSAIDs, gabapentin, acetaminophen).[6] This can be a good starting point for the young physician or physician who has not yet adopted an MMA approach in their practice. 

Enhancing Healthcare Team Outcomes

Just as successful multi-modal pain management requires different classes of medications, enhancing team outcomes requires many different types of team members. Some coordination may be required by a pain management doctor, anesthesiologist, pharmacists, PACU nurses, recovery nurses, and pre-operative nurses. Successful multi-modal pain management requires a streamlined strategy from pre-op to intra-op and post-op, including regional anesthesia, patient counseling, and multiple medications, but this has been shown to reduce narcotic usage and lead to successful postoperative pain management.[33]

References


[1]

Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. The journal of pain. 2016 Feb:17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Epub     [PubMed PMID: 26827847]

Level 1 (high-level) evidence

[2]

Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR. Morbidity and mortality weekly report. 2018 Jan 4:67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1. Epub 2018 Jan 4     [PubMed PMID: 30605448]


[3]

Jones CM, Lurie P, Woodcock J. Addressing prescription opioid overdose: data support a comprehensive policy approach. JAMA. 2014 Nov 5:312(17):1733-4. doi: 10.1001/jama.2014.13480. Epub     [PubMed PMID: 25275855]


[4]

Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011 Apr 6:305(13):1299-301. doi: 10.1001/jama.2011.401. Epub     [PubMed PMID: 21467282]


[5]

Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996:52 Suppl 5():13-23     [PubMed PMID: 8922554]

Level 3 (low-level) evidence

[6]

Hsu JR, Mir H, Wally MK, Seymour RB, Orthopaedic Trauma Association Musculoskeletal Pain Task Force. Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury. Journal of orthopaedic trauma. 2019 May:33(5):e158-e182. doi: 10.1097/BOT.0000000000001430. Epub     [PubMed PMID: 30681429]

Level 1 (high-level) evidence

[7]

Chrastil J, Sampson C, Jones KB, Higgins TF. Evaluating the affect and reversibility of opioid-induced androgen deficiency in an orthopaedic animal fracture model. Clinical orthopaedics and related research. 2014 Jun:472(6):1964-71. doi: 10.1007/s11999-014-3517-x. Epub 2014 Feb 19     [PubMed PMID: 24549775]

Level 3 (low-level) evidence

[8]

Beaudoin FL, Gutman R, Merchant RC, Clark MA, Swor RA, Jones JS, Lee DC, Peak DA, Domeier RM, Rathlev NK, McLean SA. Persistent pain after motor vehicle collision: comparative effectiveness of opioids vs nonsteroidal antiinflammatory drugs prescribed from the emergency department-a propensity matched analysis. Pain. 2017 Feb:158(2):289-295. doi: 10.1097/j.pain.0000000000000756. Epub     [PubMed PMID: 28092325]

Level 2 (mid-level) evidence

[9]

Shao Y, Zhao X, Zhai Y, Yang J, Wang S, Liu L, Wang J. Comparison of analgesic effect, knee joint function recovery, and safety profiles between pre-operative and post-operative administrations of meloxicam in knee osteoarthritis patients who underwent total knee arthroplasty. Irish journal of medical science. 2020 May:189(2):535-542. doi: 10.1007/s11845-019-02128-y. Epub 2019 Nov 15     [PubMed PMID: 31732867]


[10]

Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta poloniae pharmaceutica. 2014 Jan-Feb:71(1):11-23     [PubMed PMID: 24779190]

Level 3 (low-level) evidence

[11]

Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Archives of pharmacal research. 2013 Mar:36(3):237-51. doi: 10.1007/s12272-013-0057-y. Epub 2013 Feb 24     [PubMed PMID: 23435945]

Level 3 (low-level) evidence

[12]

Peng C, Li C, Qu J, Wu D. Gabapentin can decrease acute pain and morphine consumption in spinal surgery patients: A meta-analysis of randomized controlled trials. Medicine. 2017 Apr:96(15):e6463. doi: 10.1097/MD.0000000000006463. Epub     [PubMed PMID: 28403075]

Level 1 (high-level) evidence

[13]

Quintero GC. Review about gabapentin misuse, interactions, contraindications and side effects. Journal of experimental pharmacology. 2017:9():13-21. doi: 10.2147/JEP.S124391. Epub 2017 Feb 9     [PubMed PMID: 28223849]


[14]

Boneva N, Brenner T, Argov Z. Gabapentin may be hazardous in myasthenia gravis. Muscle & nerve. 2000 Aug:23(8):1204-8     [PubMed PMID: 10918256]

Level 3 (low-level) evidence

[15]

Koide Y, Ikeda H, Inoue Y. [Development or worsening of myoclonus associated with gabapentin therapy]. Rinsho shinkeigaku = Clinical neurology. 2009 Jun:49(6):342-7     [PubMed PMID: 19618843]

Level 3 (low-level) evidence

[16]

Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. European journal of pain (London, England). 2003:7(2):181-8     [PubMed PMID: 12600800]

Level 1 (high-level) evidence

[17]

Kenjo T, Kikuchi S, Konno S. Cooling decreases fos-immunoreactivity in the rat after formalin injection. Clinical orthopaedics and related research. 2002 Jan:(394):271-7     [PubMed PMID: 11795744]

Level 3 (low-level) evidence

[18]

Stålman A, Berglund L, Dungnerc E, Arner P, Felländer-Tsai L. Temperature-sensitive release of prostaglandin E₂ and diminished energy requirements in synovial tissue with postoperative cryotherapy: a prospective randomized study after knee arthroscopy. The Journal of bone and joint surgery. American volume. 2011 Nov 2:93(21):1961-8. doi: 10.2106/JBJS.J.01790. Epub     [PubMed PMID: 22048090]

Level 1 (high-level) evidence

[19]

Deal DN, Tipton J, Rosencrance E, Curl WW, Smith TL. Ice reduces edema. A study of microvascular permeability in rats. The Journal of bone and joint surgery. American volume. 2002 Sep:84(9):1573-8     [PubMed PMID: 12208913]

Level 3 (low-level) evidence

[20]

Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, McDonald KM, Fantini MP, Hernandez-Boussard T. Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. JAMA surgery. 2017 Oct 18:152(10):e172872. doi: 10.1001/jamasurg.2017.2872. Epub 2017 Oct 18     [PubMed PMID: 28813550]

Level 1 (high-level) evidence

[21]

Adie S, Kwan A, Naylor JM, Harris IA, Mittal R. Cryotherapy following total knee replacement. The Cochrane database of systematic reviews. 2012 Sep 12:(9):CD007911. doi: 10.1002/14651858.CD007911.pub2. Epub 2012 Sep 12     [PubMed PMID: 22972114]

Level 1 (high-level) evidence

[22]

Speer KP, Warren RF, Horowitz L. The efficacy of cryotherapy in the postoperative shoulder. Journal of shoulder and elbow surgery. 1996 Jan-Feb:5(1):62-8     [PubMed PMID: 8919444]

Level 1 (high-level) evidence

[23]

Su EP, Perna M, Boettner F, Mayman DJ, Gerlinger T, Barsoum W, Randolph J, Lee G. A prospective, multi-center, randomised trial to evaluate the efficacy of a cryopneumatic device on total knee arthroplasty recovery. The Journal of bone and joint surgery. British volume. 2012 Nov:94(11 Suppl A):153-6. doi: 10.1302/0301-620X.94B11.30832. Epub     [PubMed PMID: 23118406]

Level 1 (high-level) evidence

[24]

Whitelaw GP, DeMuth KA, Demos HA, Schepsis A, Jacques E. The use of the Cryo/Cuff versus ice and elastic wrap in the postoperative care of knee arthroscopy patients. The American journal of knee surgery. 1995 Winter:8(1):28-30; discussion 30-1     [PubMed PMID: 7866800]

Level 1 (high-level) evidence

[25]

Cohn BT, Draeger RI, Jackson DW. The effects of cold therapy in the postoperative management of pain in patients undergoing anterior cruciate ligament reconstruction. The American journal of sports medicine. 1989 May-Jun:17(3):344-9     [PubMed PMID: 2729484]

Level 1 (high-level) evidence

[26]

Ruetzler K, Blome CJ, Nabecker S, Makarova N, Fischer H, Rinoesl H, Goliasch G, Sessler DI, Koinig H. A randomised trial of oral versus intravenous opioids for treatment of pain after cardiac surgery. Journal of anesthesia. 2014 Aug:28(4):580-6. doi: 10.1007/s00540-013-1770-x. Epub 2013 Dec 28     [PubMed PMID: 24375220]

Level 1 (high-level) evidence

[27]

Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ (Clinical research ed.). 2015 Jun 10:350():h2698. doi: 10.1136/bmj.h2698. Epub 2015 Jun 10     [PubMed PMID: 26063215]

Level 3 (low-level) evidence

[28]

Singla N, Pong A, Newman K, MD-10 Study Group. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study. Clinical therapeutics. 2005 Jan:27(1):45-57     [PubMed PMID: 15763605]

Level 1 (high-level) evidence

[29]

Wojahn RD, Bogunovic L, Brophy RH, Wright RW, Matava MJ, Green JR 4th, Zalomek CA, Haas AK, Holloway WL, Garofoli EA, Smith MV. Opioid Consumption After Knee Arthroscopy. The Journal of bone and joint surgery. American volume. 2018 Oct 3:100(19):1629-1636. doi: 10.2106/JBJS.18.00049. Epub     [PubMed PMID: 30277992]


[30]

Archer KR, Castillo RC, Wegener ST, Abraham CM, Obremskey WT. Pain and satisfaction in hospitalized trauma patients: the importance of self-efficacy and psychological distress. The journal of trauma and acute care surgery. 2012 Apr:72(4):1068-77. doi: 10.1097/TA.0b013e3182452df5. Epub     [PubMed PMID: 22491629]


[31]

Pasero C. Assessment of sedation during opioid administration for pain management. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses. 2009 Jun:24(3):186-90. doi: 10.1016/j.jopan.2009.03.005. Epub     [PubMed PMID: 19500754]


[32]

McLaughlin DC, Cheah JW, Aleshi P, Zhang AL, Ma CB, Feeley BT. Multimodal analgesia decreases opioid consumption after shoulder arthroplasty: a prospective cohort study. Journal of shoulder and elbow surgery. 2018 Apr:27(4):686-691. doi: 10.1016/j.jse.2017.11.015. Epub 2018 Jan 3     [PubMed PMID: 29305103]


[33]

Moutzouros V, Jildeh TR, Khalil LS, Schwartz K, Hasan L, Matar RN, Okoroha KR. A Multimodal Protocol to Diminish Pain Following Common Orthopedic Sports Procedures: Can We Eliminate Postoperative Opioids? Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2020 Aug:36(8):2249-2257. doi: 10.1016/j.arthro.2020.04.018. Epub 2020 Apr 28     [PubMed PMID: 32353620]